Warszawa, Mazowieckie, Poland National Center for Research and Development is the famous Corporate Investor, which was founded in 2007. The main department of described Corporate Investor is located in the Warszawa. The fund was located in Europe if to be more exact in Poland.
This National Center for Research and Development works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2017. Speaking about the real fund results, this Corporate Investor is 80 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 1 - 5 millions dollars. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 deals per year.
The fund has no exact preference in a number of founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Medical Device, Apps. Among the most popular portfolio startups of the fund, we may highlight StethoMe, Pure Biologics, Billon Group. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Poland. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the National Center for Research and Development, startups are often financed by TDJ Pitango Ventures, SpeedUp Venture Capital Group, Programa. In the next rounds fund is usually obtained by Stafan Twardak, National Center for Research & Development, EASME - EU Executive Agency for SMEs.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Alphamoon | $2M | 28 Apr 2022 | Wroclaw, Dolnoslaskie, Poland | ||
Labplus | $1M | 01 Dec 2021 | Poland, Silesian Voivodeship, Poland | ||
sky crops | $1M | 27 Apr 2021 | Gliwice, Slaskie, Poland | ||
StethoMe | $1M | 01 Aug 2017 | Poznań, Greater Poland Voivodeship, Poland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Alphamoon | $2M | 28 Apr 2022 | Wroclaw, Dolnoslaskie, Poland | ||
Labplus | $1M | 01 Dec 2021 | Poland, Silesian Voivodeship, Poland | ||
sky crops | $1M | 27 Apr 2021 | Gliwice, Slaskie, Poland | ||
StethoMe | $1M | 01 Aug 2017 | Poznań, Greater Poland Voivodeship, Poland |
